Shuin-Kwei Chiou

Title: Shuin-Kwei Chiou: Innovator in Oncogene Research

Introduction

Shuin-Kwei Chiou is a notable inventor based in North Potomac, MD (US). He has made significant contributions to the field of cancer research, particularly in understanding the mechanisms of oncogenes and their interaction with p53-mediated apoptosis. His innovative work has led to the development of a patented method that could have implications for cancer treatment.

Latest Patents

Chiou holds a patent for "Cells having oncogene-suppressed p53-mediated apoptosis and methods of." This invention outlines a method for determining if a compound can modulate the ability of a putative oncogene to suppress p53-mediated effects. The method involves adding a compound to genetically engineered cells that express specific gene products and examining the cells to determine whether apoptosis has occurred. This patent highlights the potential for using genetically engineered cell lines in cancer research.

Career Highlights

Chiou is affiliated with Rutgers, the State University of New Jersey, where he continues to advance his research in oncogenes and apoptosis. His work is crucial in the ongoing battle against cancer, as it provides insights into how certain genes can inhibit cell death, which is a key factor in cancer progression.

Collaborations

Chiou has collaborated with esteemed colleagues such as Eileen White and Huey-Jen L Lin. These partnerships have likely enriched his research and contributed to the development of innovative methodologies in the field.

Conclusion

Shuin-Kwei Chiou's contributions to oncogene research and his patented methods represent significant advancements in understanding cancer biology. His work continues to inspire further research and innovation in the fight against cancer.